RA MEDICAL SYSTEMS INC (RMED) Stock Analyst Ratings
USA - NYSEARCA:RMED - US74933X3026 - Common Stock
0.594 USD
+0.05 (+10%)
0.5785 USD
-0.02 (-2.61%)
ChartMill assigns a Buy % Consensus number of 86% to RMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 1102.02% above the current price.
RMED was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about RMED.
In the previous month the buy percentage consensus was at a similar level.
RMED was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-10-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-03-17 | Maxim Group | Downgrade | Buy -> Hold |
RA MEDICAL SYSTEMS INC / RMED FAQ
What do analysts expect the price target to be for RA MEDICAL SYSTEMS INC (RMED)?
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
How do analysts rate RA MEDICAL SYSTEMS INC (RMED)?
The consensus rating for RA MEDICAL SYSTEMS INC (RMED) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed RA MEDICAL SYSTEMS INC (RMED)?
The number of analysts covering RA MEDICAL SYSTEMS INC (RMED) is 7.